Multi-omics characterization of PRMT5-associated MYC and proliferative programs in Group 3 medulloblastoma
Background: Group 3 medulloblastoma (G3-MB) carries the worst prognosis, and validated therapeutic targets downstream of MYC remain limited. We investigated PRMT5-associated molecular and clinical features in G3-MB. Methods and Results: We integrated 763 bulk transcriptomes, approximately 25,000 single-nucleus RNA-seq profiles from 12 G3-MB patients, and 144 paired methylation-expression data. PRMT5 was higher in G3-MB than in SHH tumors and was independently associated with poor overall survival in an institutional validation cohort. Its expression was not associated with copy-number gain, but correlated with promoter hypomethylation and MYC/E2F1/SP1 co-expression. Network analysis placed PRMT5 in a MYC-correlated module enriched for ribosome biogenesis. At single-nucleus resolution, PRMT5-positive tumor cells showed elevated MYC and proliferation programs, although these associations were sensitive to detection threshold and library size. PRMT5-high tumors showed expression of genes linked to PRMT5-inhibitor pathways, DNA damage response, and replication stress. An exploratory seven-gene PRMT5-associated continuous score showed prognostic signal in the training and institutional validation cohorts. Conclusions: Integrated analyses associate PRMT5 with MYC-linked ribosome biogenesis and proliferative programs in G3-MB. PRMT5 is a candidate prognostic marker, and the PRMT5-MYC-ribosome association is a testable preclinical hypothesis; functional studies are needed to establish therapeutic relevance.
Authors
- 王子卫
- Kaiwen Deng (ORCID: https://orcid.org/0009-0002-2455-4596)
- Zhiyang Chen (ORCID: https://orcid.org/0009-0002-8460-2633)
- Zhaoyang Feng (ORCID: https://orcid.org/0009-0005-4781-2780)
- Liu Yu
- Hailong Liu (ORCID: https://orcid.org/0000-0003-2488-1239)
- Yuyan Liang
- Dongyang Wang
- Fei Liu
- Yu Su
- Junyuan Tian
- Xuan Chen
- Wei Wang
- Xi Cheng
- Tao Jiang
- Qiao Yang
- Xiangceng Liu
Institutions
- University of Electronic Science and Technology of China (CN)
- Capital Medical University (CN)
- Beijing Tian Tan Hospital (CN)
- Beijing Children’s Hospital (CN)
- Beijing YouAn Hospital (CN)
- University of Chinese Academy of Sciences (CN)
- BGI Research, Wuhan (CN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-18
- DOI
- https://doi.org/10.21203/rs.3.rs-11632170/v1
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- preprint
Funders
- National Natural Science Foundation of China